Eurofarma Laboratórios S.A. Stock

Stocks

EUFA3

BREUFAACNOR4

Market Closed - Sao Paulo			5-day change	1st Jan Change
- ^BRL	-.--%		-.--%	-

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Latest news: Eurofarma Laboratórios S.A.

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
01-23	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil	CI
12-10	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors	CI
11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-21	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer	CI
25-10-21	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform	CI
25-08-21	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-03-16	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.	CI
24-11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

More news

Managers and Directors: Eurofarma Laboratórios S.A.

Manager	Title	Age	Since
Marco Billi CEO	Chief Executive Officer	-	2021-11-22
Alexandre Mendes Palhares IRC	Investor Relations Contact	40	2021-11-22

Director	Title	Age	Since
Maurízio Billi CHM	Chairman	-	2021-11-22
Cristina Presz Palmaka de Luca BRD	Director/Board Member	58	2021-11-22
Juliana Rozenbaum Munemori BRD	Director/Board Member	50	2018-12-31

More insiders

Latest insider transactions

Date	Insider	Type	Quantity	% Market Cap.
1/10/25	Controlling Shareholder Brazilian	Buy	1,644,236	0.1665%
12/4/24	Controlling Shareholder Brazilian	Sell	15,405,639	1.5600%
12/4/24	Controlling Shareholder Brazilian	Buy	15,405,639	1.5600%

Transaction History

Financials

	2024	2025
Net sales	10.97B 2.19B 1.95B 1.82B 1.66B 3.11B 212B 3.15B 21.83B 8.53B 108B 8.22B 8.04B 346B	12.48B 2.49B 2.22B 2.07B 1.88B 3.54B 241B 3.58B 24.82B 9.7B 123B 9.35B 9.15B 393B
Net income	117M 23.41M 20.85M 19.46M 17.69M 33.27M 2.27B 33.64M 233M 91.22M 1.15B 87.84M 85.96M 3.69B	571M 114M 102M 94.84M 86.2M 162M 11.04B 164M 1.14B 444M 5.63B 428M 419M 18B
Net Debt	-	-

Projected Income Statement - Annual - Eurofarma Laboratórios S.A.

* Estimated data More financial data

Company Profile

Employees

13,000

Sector

More about the company